C H Blood

1.0k total citations · 1 hit paper
10 papers, 883 citations indexed

About

C H Blood is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, C H Blood has authored 10 papers receiving a total of 883 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in C H Blood's work include Protease and Inhibitor Mechanisms (5 papers), Cancer Treatment and Pharmacology (4 papers) and Microbial Natural Products and Biosynthesis (3 papers). C H Blood is often cited by papers focused on Protease and Inhibitor Mechanisms (5 papers), Cancer Treatment and Pharmacology (4 papers) and Microbial Natural Products and Biosynthesis (3 papers). C H Blood collaborates with scholars based in United States and United Kingdom. C H Blood's co-authors include Bruce R. Zetter, Joachim Sasse, Pnina Brodt, Min Chu, Toshikazu Yusa, Wolfram Bode, Daizhou Zhang, F. George Njoroge, E. F. Meyer and Istvan Botos and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

C H Blood

10 papers receiving 847 citations

Hit Papers

Tumor interactions with t... 1990 2026 2002 2014 1990 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C H Blood United States 9 481 318 221 204 183 10 883
Laura A. Rudolph‐Owen United States 10 763 1.6× 336 1.1× 361 1.6× 134 0.7× 113 0.6× 12 1.2k
Yoshihiro Mitsuhashi Japan 10 866 1.8× 409 1.3× 455 2.1× 82 0.4× 57 0.3× 11 1.2k
IR Hart United Kingdom 14 594 1.2× 168 0.5× 317 1.4× 151 0.7× 97 0.5× 18 976
Gaynor Davies United Kingdom 19 576 1.2× 255 0.8× 351 1.6× 141 0.7× 43 0.2× 22 1.0k
Eric C. McGary United States 15 628 1.3× 205 0.6× 480 2.2× 98 0.5× 67 0.4× 22 1.1k
Grace Ziegler United States 8 465 1.0× 503 1.6× 221 1.0× 174 0.9× 34 0.2× 8 894
Shuichi Ikeyama Japan 10 546 1.1× 191 0.6× 270 1.2× 307 1.5× 35 0.2× 13 901
Sadako Yamagata Japan 19 580 1.2× 359 1.1× 275 1.2× 145 0.7× 57 0.3× 47 1.1k
Ricardo López de Cicco United States 15 567 1.2× 324 1.0× 363 1.6× 68 0.3× 85 0.5× 20 1.0k
Mary Jo Murnane United States 19 637 1.3× 378 1.2× 242 1.1× 106 0.5× 81 0.4× 32 1.2k

Countries citing papers authored by C H Blood

Since Specialization
Citations

This map shows the geographic impact of C H Blood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C H Blood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C H Blood more than expected).

Fields of papers citing papers by C H Blood

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C H Blood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C H Blood. The network helps show where C H Blood may publish in the future.

Co-authorship network of co-authors of C H Blood

This figure shows the co-authorship network connecting the top 25 collaborators of C H Blood. A scholar is included among the top collaborators of C H Blood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C H Blood. C H Blood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Chu, Min, Imbi Truumees, Mahesh Patel, et al.. (1995). Sch S0673 and Sch 50676, Two Novel Antitumor Fungal Metabolites.. The Journal of Antibiotics. 48(4). 329–331. 20 indexed citations
2.
King, I., C H Blood, Ming Chu, et al.. (1995). Antitumor effect of keto-diepoxides isolated from the fungus Nattrassia mangiferae.. PubMed. 7(1). 1–5. 1 indexed citations
3.
Zhang, Daizhou, Istvan Botos, F. Xavier Gomis‐Rüth, et al.. (1994). Structural interaction of natural and synthetic inhibitors with the venom metalloproteinase, atrolysin C (form d).. Proceedings of the National Academy of Sciences. 91(18). 8447–8451. 112 indexed citations
4.
Chu, Min, Imbi Truumees, Mahesh Patel, et al.. (1994). A novel class of antitumor metabolites from the fungus Nattrassia Mangiferae. Tetrahedron Letters. 35(9). 1343–1346. 41 indexed citations
5.
Pai, Jin-Keon, et al.. (1994). Novel ketoepoxides block phospholipase D activation and tumor cell invasion.. PubMed. 9(4). 363–72. 19 indexed citations
6.
Blood, C H & Bruce R. Zetter. (1993). Laminin regulates a tumor cell chemotaxis receptor through the laminin-binding integrin subunit alpha 6.. PubMed. 53(11). 2661–6. 14 indexed citations
7.
Blood, C H. (1990). Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1032(1). 89–118. 507 indexed citations breakdown →
8.
Blood, C H & Bruce R. Zetter. (1989). Membrane-bound Protein Kinase C Modulates Receptor Affinity and Chemotaetic Responsiveness of Lewis Lung Carcinoma Sublines to an Elastin-derived Peptide. Journal of Biological Chemistry. 264(18). 10614–10620. 42 indexed citations
9.
Yusa, Toshikazu, C H Blood, & Bruce R. Zetter. (1989). Tumor Cell Interactions with Elastin: Implications for Pulmonary Metastasis. American Review of Respiratory Disease. 140(5). 1458–1462. 38 indexed citations
10.
Blood, C H, Joachim Sasse, Pnina Brodt, & Bruce R. Zetter. (1988). Identification of a tumor cell receptor for VGVAPG, an elastin-derived chemotactic peptide.. The Journal of Cell Biology. 107(5). 1987–1993. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026